The New York TimesPfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries (Published 2021)Nov 16, 2021Rebecca Robbins & Stephanie NolenBy Rebecca Robbins & Stephanie Nolenmore_vert
NBC NewsPfizer asks FDA to authorize Covid antiviral pillsNov 16, 2021Sara G. MillerBy Sara G. Millermore_vert
The New York TimesCoronavirus: Covid News: D.C. Eases Indoor Mask Restrictions (Published 2021)Mar 20, 2023Dan Levin, Sharon LaFraniere & Rebecca RobbinsBy Dan Levin, Sharon LaFraniere & Rebecca Robbinsmore_vert
Medical XpressPfizer, BioNTech, Moderna making $1,000 profit every second: analysisNov 16, 2021more_vert
BBC.comCovid booster doses will be offered to over-40sNov 15, 2021James GallagherBy James Gallaghermore_vert
The Wall Street JournalPfizer Submits Covid-19 Pill for FDA AuthorizationNov 16, 2021Jared S. HopkinsBy Jared S. Hopkinsmore_vert
The US SunCovid booster jab: The ‘winter’ side effect to watch out for in feet after the vaccine...Nov 15, 2021Vanessa ChalmersBy Vanessa Chalmersmore_vert
The Washington PostPfizer to share license for covid-19 pill, potentially opening up treatment to millions in low-income nationsNov 16, 2021Adam Taylor & Claire ParkerBy Adam Taylor & Claire Parkermore_vert
NPRPfizer asks the FDA to authorize use of its COVID pillNov 16, 2021Bill ChappellBy Bill Chappellmore_vert
The New York TimesPfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated PeopleNov 18, 2021Rebecca RobbinsBy Rebecca Robbinsmore_vert